Patent Assignment
Reel/Frame 031628/0850
Security Agreement
Recorded: 2013-11-13
Pages: 13
Assignors
OPTIMER PHARMACEUTICALS, INC.
Executed: 2013-11-12
TRIUS THERAPEUTICS INC.
Executed: 2013-11-12
Assignee
ROYAL BANK OF CANADA, AS ADMINISTRATIVE AGENT
4TH FLOOR, KING STREET WEST, TORONTO, M5H 1C4, CANADA
Covered Properties
(40)
Tricyclic Gyrase Inhibitors
PCT:
PCT/US2013/059310 ↗
Tiacumicin Production
Novel Oxazolidinone Derivatives
Identification and Application of Antibiotic Synergy
Method for Identifying Drug-Sensitizing Antisense Dna Fragments and Use Thereof
Polymorphic Crystalline Forms of Tiacumicin B
18-Membered Macrocycles and Analogs Thereof
Antimicrobial Compositions and Methods of Use
Application:
12/027,950 →
Publication:
US 2008/0194545
Macrolide Polymorphs, Compositions Comprising Such Polymorphs, and Methods of Use and Manufacture Thereof
Novel Oxazolidinone Derivatives
Antibiotic Macrocycle Compounds and Methods of Mnaufacture and Use Thereof
Macrolide Polymorphs, Compositions Comprising Such Polymorphs, and Methods of Use and Manufacture Thereof
Macrocyclic Polymorphs, Compositions Comprising Such Polymorphs, and Methods of Use and Manufacture Thereof
18-Membered Macrocycles and Analogs Thereof
Macrocyclic Polymorphs, Compositions Comprising Such Polymorphs and Methods of Use and Manufacture Thereof
Methods for Preparing Oxazolidinones and Compositions Containing Them
Crystalline Form of R)-3-(4-(2-(2-Methyltetrazol-5-Yl)Pyridin- 5-Yl)-3-Fluorophenyl)-5-Hydroxymethyl Oxazolidin-2-One Dihydrogen Phosphate
Oxazolidinone Containing Dimer Compounds, Compositions and Methods to Make and Use
Identification and Application of Antibiotic Synergy
Dihydrofolate Reductase Inhibitors
Antibiotic Macrocycle Compounds and Methods of Manufacture and Use Thereof
Gyrase Inhibitors
Compositions of Stable Tiacumicins
Application:
13/416,768 →
Publication:
US 2013/0065844
Treatment of Disease Associated with the Use of Antibiotics
Application:
13/457,216 →
Publication:
US 2013/0274175
Tiacumicin Production
Tricyclic Gyrase Inhibitors
Therapeutic Combination of Daptomycin and Protein Synthesis Inhibitor Antibiotic, and Methods of Use
Treatment of Clostridium Difficile Infection In Patients Undergoing Antibiotic Therapy
Application:
13/698,958 →
Methods of Treating Recurring Bacterial Infection
Application:
13/698,963 →
Method of Treating Clostridium Difficile-Associated Diarrhea
Application:
13/723,881 →
Publication:
US 2014/0107054
Antibiotic Macrocycle Compounds and Methods of Manufacture and Use Thereof
18-Membered Macrocycles and Analogs Thereof
Application:
13/838,634 →
Publication:
US 2013/0252913
Macrolide Polymorphs, Compositions Comprising Such Polymorphs, and Methods of Use and Manufacture Thereof
Application:
13/839,299 →
Publication:
US 2013/0252914
Novel Oxazolidinone Derivatives
Forms of R)-3-(4-(2-(2-Methyltetrazol-5-Yl)Pyridin- 5-Yl)-3-Fluorophenyl)-5-Hydroxymethyl Oxazolidin-2-One Dihydrogen Phosphate
Application:
13/867,951 →
Publication:
US 2013/0310343
Therapeutic Combination of Daptomycin and Protein Synthesis Inhibitor Antibiotic, and Methods of Use
Application:
13/911,990 →
Publication:
US 2013/0274174
Treatment of Bacterial Infections
Application:
61/552,383 →
Prevention of Clostridium Difficile Infection in High Risk Patients
Application:
61/611,965 →
Tricyclic Gyrase Inhibitors
Application:
61/876,688 →
Methods of Treating Subjects with Renal Impairment Using Tedizolid
Application:
61/887,571 →
Related Assignments
(9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 31, 2012
From: RHEE, JAE KEOL; IM, WEON BIN; CHO, CHONG HWAN; CHOI, SUNG HAK
To: DONG-A PHARM. CO., LTD.
Reel/Frame 028299/0412 →
Assignment of Assignor's Interest
Jul 23, 2013
From: DONG-A SOCIO HOLDINGS CO., LTD
To: DONG-A ST CO., LTD
Reel/Frame 030859/0352 →
Assignment of Assignor's Interest
Jul 17, 2014
From: PHILLIPSON, DOUGLAS
To: TRIUS THERAPEUTICS, INC.
Reel/Frame 033337/0257 →
Release of Security Interest
Jul 24, 2015
From: ROYAL BANK OF CANADA, AS ADMINISTRATIVE AGENT
To: TRIUS THERAPEUTICS, INC.; OPTIMER PHARMACEUTICALS, INC.
Reel/Frame 036178/0175 →
Change of Name
Aug 12, 2015
From: OPTIMER PHARMACEUTICALS, INC.
To: OPTIMER PHARMACEUTICALS LLC
Reel/Frame 036333/0793 →
Nunc Pro Tunc Assignment
Aug 14, 2015
From: OPTIMER PHARMACEUTICALS LLC
To: MERCK SHARP & DOHME CORP.
Reel/Frame 036328/0122 →
Change of Name
Sep 2, 2015
From: TRIUS THERAPEUTICS, INC.
To: TRIUS THERAPEUTICS LLC
Reel/Frame 036528/0029 →
Nunc Pro Tunc Assignment
Sep 3, 2015
From: TRIUS THERAPEUTICS LLC
To: MERCK SHARP & DOHME CORP.
Reel/Frame 036484/0796 →
Merger
Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →